These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

37 related articles for article (PubMed ID: 13704959)

  • 1. Studies on antigens of Vibrio cholerae by gel diffusion technique. III. Antigenic make-up of phage types.
    GHOSH SN; MUKERJEE S
    Ann Biochem Exp Med; 1961 Apr; 21():99-104. PubMed ID: 13704959
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on antigens of Vibrio cholerae by gel diffusion technique. IV. Antigenic relationship between non-agglutinating and agglutinating vibrios.
    GHOSH SN; MUKERJEE S
    Ann Biochem Exp Med; 1961 Jul; 21():183-90. PubMed ID: 13704960
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on antigens of Vibrio cholerae by gel diffusion technique. II. Further observations on the antigenic analysis of materials soluble in water.
    GHOSE SN; MUKERJEE S
    Ann Biochem Exp Med; 1961 Jun; 21():151-6. PubMed ID: 13704950
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification and characterization of phage PS166 lysogens from non-O1, O139 strains of Vibrio cholerae.
    Basu S; Ghosh RK
    Med Sci Monit; 2009 Oct; 15(10):BR281-288. PubMed ID: 19789504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new vaccinating antigenic fraction obtained from "Vibrio cholerae" I.--Isolation and characterization of the new fraction (author's transl)].
    Dodin A; Wiart J
    Ann Microbiol (Paris); 1975 Jan; 126(1):39-44. PubMed ID: 811146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ability of two different Vibrio spp. bacteriophages to infect Vibrio harveyi, Vibrio cholerae and Vibrio mimicus.
    Payne M; Oakey J; Owens L
    J Appl Microbiol; 2004; 97(4):663-72. PubMed ID: 15357715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The curing of alpha-phage by superinfection with VcA-1 phage in Vibrio cholerae.
    Siddiqui KA; Bhattacharyya FK
    J Diarrhoeal Dis Res; 1983 Jun; 1(2):107-8. PubMed ID: 6680121
    [No Abstract]   [Full Text] [Related]  

  • 8. Isolation and characterization of unserotypable lysogens of Vibrio cholerae phage PS166.
    Basu S; Ghosh RK
    Med Sci Monit; 2005 Sep; 11(9):BR335-42. PubMed ID: 16127356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vibrio cholerae temperate phage O139: characteristics and role in changing expression of chromosomal virulence genes].
    Smirnova NI; Eroshenko GA; Shchelkanova EIu; Livanova LF; Konnov NP
    Mol Gen Mikrobiol Virusol; 1999; (1):3-9. PubMed ID: 10190102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of adsorption of a group IV cholera phage.
    Maiti M; Chatterjee SN
    Bull Calcutta Sch Trop Med; 1971 Apr; 19(2):35-7. PubMed ID: 5161466
    [No Abstract]   [Full Text] [Related]  

  • 11. Conversion of Vibrio eltor MAK757 to classical biotype: role of phage PS166.
    Mitra SN; Mukhopadhyay R; Ghosh AN; Ghosh RK
    Virology; 2000 Jul; 273(1):36-43. PubMed ID: 10891405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phage 4 and polymyxin B sensitivity of rough strains of classicial V. Cholerae.
    Neogy KN; Sanyal SN
    Bull Calcutta Sch Trop Med; 1968 Jan; 16(1):16. PubMed ID: 4306087
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vibrio cholerae VPI phi/CTX phi/TCP: interactions of phage-phage-bacterium].
    Ai Y; Meng F
    Wei Sheng Wu Xue Bao; 2001 Aug; 41(4):510-2. PubMed ID: 12552921
    [No Abstract]   [Full Text] [Related]  

  • 14. Basic criteria and classification scheme for bacteriophages acting against cholera vibrios of the classical and El Tor biotypes.
    Bystryi NF; Drozhevkina MS
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(1):85-94. PubMed ID: 574886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Improved method of releasing the phage from pseudolysogenic clones of Vibrio cholerae].
    Arutiunov IuI; Drozhevkina MS
    Lab Delo; 1982; (11):683-5. PubMed ID: 6184536
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of moderate bacteriophage 139 in change in production of cholera toxin in a classic strain of Vibrio cholerae].
    Eroshenko GA; Smirnova NI
    Genetika; 2004 Apr; 40(4):445-53. PubMed ID: 15174276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and molecular typing of Vibrio cholerae O1 and O139 isolates from India.
    Bhowmick TS; Das M; Roy N; Sarkar BL
    J Infect; 2007 May; 54(5):475-82. PubMed ID: 17087996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Vibrio cholerae O1 ElTor typing phage S5.
    Mitra K; Ghosh AN
    Arch Virol; 2007; 152(10):1775-86. PubMed ID: 17610123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic control of Vibrio cholerae pathogenicity: the temperate filamentous phage CTX, coding for cholera toxin and the "island of pathogenicity"].
    Smirnova NI
    Mol Gen Mikrobiol Virusol; 1999; (4):3-11. PubMed ID: 10621931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Functional analysis of promoters of Vibrio cholerea typing phage VP1 with reporter system].
    Li YP; Liang WL; Wang DC; Qi GM; Kan B; Gao SY; Liu YQ
    Wei Sheng Wu Xue Bao; 2005 Dec; 45(6):846-50. PubMed ID: 16496689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.